Colorimetric methods for in vitro antifungal susceptibility testing;Métodos colorimétricos para la determinación de la sensibilidad in vitro a los antifúngicos

Revista Iberoamericana de Micologia

Volumn 18, Issue 4, 2001, Pages 150-155

  Carrillo Muñoz, Alfonso Javier ^a   Abarca, Lourde ^a   Quindós, Guillermo ^a  

^a NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 (1,2 DIHYDRO 2 OXO 1 PYRIDYL) 1,2 DIHYDRO 2,2 DIMETHYL 1 OXONAPHTHALENE 6 CARBONITRILE; ALBACONAZOLE; AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; NYSTATIN; RAVUCONAZOLE; VORICONAZOLE;

COLORIMETRY; DRUG SENSITIVITY; MICROBIOLOGY; MINIMUM INHIBITORY CONCENTRATION; MYCOLOGY; SHORT SURVEY; STANDARD;

EID: 19244379611     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (43)

1. The national nosocomial infection surveillance system. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990
2. Fungal infections in the transplant recipient and laboratory methods for diagnosis
3. Epidemiology of nosocomial fungal infections in the 1990s
4. Disseminated Scedosporium inflatum infection in a patient with accute myeloblastic leukemia
5. Characterization of Scedosporium prolificans clinical isolates by random amplification polymorphic DNA analysis
6. Emerging fungal pathogens, drug resistance and the role of lipid formulations of amphotericin B in the treatment of fungal infections in cancer patients: A review
7. Avances en el diagnóstico de la candidiasis sistémica
8. Mycotic infections in the immunocompromised patient
9. Tratamiento de las candidiasis orofaríngeas
10. Nuevos antifúngicos
11. Una nueva generación de fármacos antifúngicos
12. Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes?
13. Should resistance to azole antifungals in vitro be interpreted as predicting clinical non-response?
14. Clinical utility of in vitro antifungal susceptibility testing
15. In vitro antifungal susceptibility methods and clinical applications of antifungal resistance
16. Métodos de estudio de la sensibilidad a los antifúngicos. I. Factores y variables que influyen en su realización en el laboratorio
17. Comité para la Estandarización de los Antifúngicos de la Asociación Española de Micología. Aportaciones del comité de la AEM a la estandarización de las pruebas de estudio de la sensibilidad in vitro a los antifúngicos
18. Evaluación de un método de difusión en agar para el estudio de la sensibilidad in vitro a los antifúngicos frente a cepas de referencia
19. Antifungal susceptibility testing
20. Las pruebas de sensibilidad antifúngica en un laboratorio de microbiología clínica
21. Determinación mediante el sistema sensititre® de la sensibilidad in vitro a los antifúngicos en levaduras de interés clínico
22. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeasts isolates
23. Multisite reproducibility of colorimetric broth microdilution method for antifungal susceptibility testing of yeasts isolates
24. Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing
25. Comparative evaluation of Fungitest and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans
26. Comparative evaluation of Fungitest, NeoSensitabs and M27-A NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans
27. Evaluation of the Fungitest kit by using strains form human immunodeficiency virus-infected patients: Study of azole drug susceptibility
28. Multicenter evaluation of ATB Fungus: A standardized micromethod for yeast susceptibility testing
29. Evaluación de la sensibilidad a los antifúngicos de aislamientos clínicos de los serotipos A y B de Candida albicans mediante el método ATB Fungus
30. Study of susceptibility of yeast isolates of clinical interest to five antifungal agents using the E-test
31. Concentraciones mínimas inhibitorias de levaduras a cinco antifúngicos utilizando un micrométodo de dilución estandarizado y E-test
32. Las pruebas in vitro en la evaluación de los agentes antifúngicos
33. Sistemas de valoración in vitro de los antifúngicos
34. Comparative evaluation of macrodilution and Alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates
35. Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing
36. Comparison of Etest, microdilution and colorimetric dilution with reference broth macrodilution method for antifungal susceptibility testing of clinically significant Candida species isolated from immunocompromised patients
37. Comercial systems for fluconazole susceptibility testing of yeasts: Comparison with the broth microdilution method
38. Multicenter comparison of the Sensititre yeast one colorimetric antifungal panel with the national committee for clinical laboratory standard M27 - A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms
39. Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp
40. Fluconazole susceptibilities of bloodstream Candida spp. Isolates as determined by National Committee for Clinical Laboratory Standards Meted M27-A and two other methods
41. Use of amphotericin B with azole antifungal drugs. What are we doing?